Details
Stereochemistry | ACHIRAL |
Molecular Formula | C40H58N4.2Cl |
Molecular Weight | 665.821 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].CC1=[N+]2CCCCCCCCCC[N+]3=C(C)C=C(NCCCCCCCCCCNC(=C1)C4=CC=CC=C24)C5=CC=CC=C35
InChI
InChIKey=ZTPJEWMQRZXADZ-BGRABRFLSA-N
InChI=1S/C40H56N4.2ClH/c1-33-31-37-35-23-15-17-25-39(35)43(33)29-21-13-9-5-6-10-14-22-30-44-34(2)32-38(36-24-16-18-26-40(36)44)42-28-20-12-8-4-3-7-11-19-27-41-37;;/h15-18,23-26,31-32H,3-14,19-22,27-30H2,1-2H3;2*1H/b41-37+,42-38+;;
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C40H56N4 |
Molecular Weight | 592.8994 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/3268636Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3141752 | https://www.ncbi.nlm.nih.gov/pubmed/6573701
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3268636
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/3141752 | https://www.ncbi.nlm.nih.gov/pubmed/6573701
Bisdequalinium (also known as R-199, trade name Solvidont) is an antibacterial agent for endodontic use. Bisdequalinium was available in three dispensing forms: an irrigation solution, a working solution, and a medication paste. They contained 0.125 %, 0.5 %, and 0.48 % Bisdequalinium respectively. The low cytotoxicity and high antimicrobial effects, detergent, and lubricating and chelating properties, all claimed in the manufacturer's brochure, make this material an appropriate candidate for clinical endodontic use.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3268636
Bisdequalinium was available in three dispensing forms: an irrigation solution, a working solution, and a medication paste. They contained 0.125 %, 0.5 %, and 0.48 % Bisdequalinium respectively.
Route of Administration:
Dental
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3268636
L929 mouse fibroblasts cells were used for cytotoxicity evaluation. The culture medium used was minimal essential medium with Eagle's salts (Flow Laboratories, McLean, VA). Ten percent (vol/vol) fetal calf serum, 2 mM L-glutamine, and 2.2 mg of sodium bicarbonate per ml were added to the medium. Antibiotics at a concentration of 50 mkg of streptomycin and 100 IU of penicillin per ml were also added to the medium. The cells, media, procedures for radiochromium
labeling of the target cells. In order to prepare desired concentrations of Bisdequalinium for the experiments, the stock Bisdequalinium solutions (0.125% Bisdequalinium) were diluted in the culture medium. One milliliter of the test solution was mixed with 1 ml of the labeled cell suspension in a test tube and incubated at 37C The test tubes were then centrifuged (500 x g), and the supernatants were counted in a gamma particle counter. The percentage of radiochromium release was calculated on the basis of the total amount of label incorporated in the target cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:02:48 GMT 2023
by
admin
on
Sat Dec 16 02:02:48 GMT 2023
|
Record UNII |
INQ1WJ5T1A
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3030
Created by
admin on Sat Dec 16 02:02:48 GMT 2023 , Edited by admin on Sat Dec 16 02:02:48 GMT 2023
|
PRIMARY | |||
|
m1029
Created by
admin on Sat Dec 16 02:02:48 GMT 2023 , Edited by admin on Sat Dec 16 02:02:48 GMT 2023
|
PRIMARY | Merck Index | ||
|
52951-36-7
Created by
admin on Sat Dec 16 02:02:48 GMT 2023 , Edited by admin on Sat Dec 16 02:02:48 GMT 2023
|
PRIMARY | |||
|
SUB13076MIG
Created by
admin on Sat Dec 16 02:02:48 GMT 2023 , Edited by admin on Sat Dec 16 02:02:48 GMT 2023
|
PRIMARY | |||
|
100000076861
Created by
admin on Sat Dec 16 02:02:48 GMT 2023 , Edited by admin on Sat Dec 16 02:02:48 GMT 2023
|
PRIMARY | |||
|
INQ1WJ5T1A
Created by
admin on Sat Dec 16 02:02:48 GMT 2023 , Edited by admin on Sat Dec 16 02:02:48 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |